Sionna Therapeutics, Inc.
SION
$42.18
-$0.59-1.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -62.47% | -28.98% | 20.29% | -111.27% | -39.12% |
| Total Depreciation and Amortization | -3.14% | -8.98% | 11.83% | -11.45% | -4.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 262.39% | 418.85% | -67.68% | 504.47% | 83.66% |
| Change in Net Operating Assets | -11.01% | -109.63% | 220.80% | -13.18% | 26.53% |
| Cash from Operations | -34.09% | -41.13% | 13.89% | -78.94% | -23.63% |
| Capital Expenditure | -- | -655.56% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 117.59% | 49.41% | 122.82% | 18.78% | -13.86% |
| Cash from Investing | 117.58% | 48.33% | 121.99% | 18.78% | -13.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.91% | 6,536.00% | 2,604.11% | -- | 4,047,680.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.06% | 217.83% | 298.19% | -921.05% | 11.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.15% | 273.76% | 218.98% | -7.70% | 1.53% |